P-082. Endometriosis and in-vitro fertilization: a metaanalysis

In: Human Reproduction · 1999 · vol. 14(Suppl_3) , pp. 181 · doi:10.1093/humrep/14.suppl_3.181-a · W2588083791
OA: bronze CC0 ⤵ 5 in-corpus citations
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This meta-analysis assessed the impact of endometriosis on uterine blood flow in women undergoing in-vitro fertilization and hormonal replacement therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

and the remammg 53 were non-cycling women. Cycling recipients underwent pituitary down-regulation using GnRH analogue from the midluteal phase of the previous cycle. All patients received hormonal replacement therapy (HRT) with increasing oral doses of micronized 17p-oestradiol starting on day 2 of the cycle. The luteal phase was supported with oily progesterone (100 mg/day/i.m.) and vaginal micronized progesterone (400 mg/day). Recipients' uterine BFV [expressed as pulsatility index (PI)] was assessed by transvaginal colour Doppler ultrasound on day 2 of an HRT previous cycle and on the day of progesterone commencement. Data was analysed using Student's t-test and Fisher's exact test.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK